Choudhuri Bodhisatwa, Agarwal Nishant
Critical Care and Rheumatology, Parkview Super Specialty Hospital, Kolkata, IND.
Emergency Medicine, Charnock Hospital, Kolkata, IND.
Cureus. 2025 Feb 5;17(2):e78560. doi: 10.7759/cureus.78560. eCollection 2025 Feb.
Sildenafil, a phosphodiesterase-5 (PDE5) inhibitor, is widely used for erectile dysfunction and pulmonary hypertension, with its cardiovascular safety profile being well documented. However, its potential to induce conduction abnormalities remains largely unexplored, both due to a lack of clinical reports and limited mechanistic studies. While tachyarrhythmias have been frequently associated with sildenafil use, bradyarrhythmias, particularly complete heart block, are an unreported complication. We present the case of a young, healthy male who developed a transient complete heart block shortly after sildenafil ingestion. Despite no prior cardiac history and normal coronary angiography, he experienced severe bradycardia unresponsive to atropine but reverted to normal sinus rhythm with isoprenaline infusion. Mechanistically, sildenafil-induced hypotension, autonomic modulation, or transient myocardial ischemia may have contributed to atrioventricular (AV) nodal suppression. Previous reports have linked sildenafil to myocardial infarction and ventricular arrhythmias, but to our knowledge, no cases of transient complete heart block have been documented. This case expands the understanding of sildenafil's electrophysiological effects, emphasizing the need for awareness among clinicians prescribing PDE5 inhibitors. Further research is warranted to assess risk stratification for patients susceptible to sildenafil-induced conduction abnormalities.
西地那非是一种磷酸二酯酶-5(PDE5)抑制剂,广泛用于治疗勃起功能障碍和肺动脉高压,其心血管安全性已有充分记录。然而,由于缺乏临床报告和有限的机制研究,其诱发传导异常的可能性在很大程度上尚未得到探索。虽然室上性心律失常经常与使用西地那非有关,但缓慢性心律失常,特别是完全性心脏传导阻滞,是一种未报告的并发症。我们报告一例年轻健康男性在服用西地那非后不久出现短暂性完全性心脏传导阻滞的病例。尽管他既往无心脏病史且冠状动脉造影正常,但他出现了严重心动过缓,对阿托品无反应,但在输注异丙肾上腺素后恢复为正常窦性心律。从机制上讲,西地那非引起的低血压、自主神经调节或短暂性心肌缺血可能导致了房室(AV)结抑制。既往报告将西地那非与心肌梗死和室性心律失常联系起来,但据我们所知,尚无短暂性完全性心脏传导阻滞的病例记录。该病例扩展了对西地那非电生理效应的认识,强调了开具PDE5抑制剂的临床医生需要提高认识。有必要进行进一步研究,以评估易发生西地那非诱发传导异常患者的风险分层。